New Key Statistics Module, Z-Score and F-Score
OTCPK:OPHLY Key Ratios
Market Cap $ M | 6,805.72 |
Enterprise Value $ M | 5,745.60 |
P/E(ttm) | 7.90 |
PE Ratio without NRI | 7.90 |
Forward PE Ratio | -- |
Price/Book | 1.36 |
Price/Sales | 2.15 |
Price/Free Cash Flow | 12.06 |
Price/Owner Earnings | 10.37 |
Payout Ratio % | 0.15 |
Revenue (TTM) $ M | 3,451.00 |
EPS (TTM) $ | 0.61 |
Beneish M-Score | -2.21 |
10-y EBITDA Growth Rate % | 21.40 |
5-y EBITDA Growth Rate % | 20.30 |
y-y EBITDA Growth Rate % | 14.40 |
EV-to-EBIT | 5.10 |
EV-to-EBITDA | 4.59 |
PEG | 0.39 |
Shares Outstanding M | 1,409.08 |
Net Margin (%) | 25.46 |
Operating Margin % | 31.82 |
Pre-tax Margin (%) | 32.57 |
Quick Ratio | 3.52 |
Current Ratio | 3.99 |
ROA % (ttm) | 14.36 |
ROE % (ttm) | 16.58 |
ROIC % (ttm) | 19.03 |
Dividend Yield % | 1.88 |
Altman Z-Score | 8.41 |
OPHLY Number of Guru Trades
OPHLY Volume of Guru Trades
Gurus Latest Trades with OTCPK:OPHLY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:OPHLY is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Ono Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:OPHLY
Total 0- 1